- $1.30bn
- $1.01bn
- $266.95m
Brief: Walkme Posts Q2 Revenue Of $46.8 Million
U.S. STOCKS ON THE MOVE-Tempest Therapeutics, Celldex Therapeutics, 23andMe, Didi
WalkMe up as brokerages initiate coverage
Brief: Walkme - KeyBanc Starts With Overweight Rating Price Target $42
U.S. RESEARCH ROUNDUP- American Express, Rocket Companies, Walkme
Brief: Walkme Ltd Shares Open $31.25 In Nasdaq Debut vs IPO Price of $31.00/Share
NASDAQ RESUMED AT 11:56 AM
NASDAQ TRADE HALT CONTINUES IPO SECURITY RELEASED FOR QUOTATION AT 11:16 AM
NASDAQ RESUMED AT 11:16 AM
NASDAQ TRADE HALT CONTINUES IPO SECURITY RELEASED FOR QUOTATION AT 10:17 AM
NASDAQ RESUMED AT 10:17 AM
NASDAQ TRADE HALT CONTINUES IPO SECURITY RELEASED FOR QUOTATION AT 10:16 AM
NASDAQ RESUMED AT 10:16 AM
NASDAQ TRADE HALT CONTINUES IPO SECURITY RELEASED FOR QUOTATION AT 10:15 AM
NASDAQ RESUMED AT 10:15 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 10:02 AM
NASDAQ RESUMED AT 10:03 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 10:01 AM
NASDAQ RESUMED AT 10:01 AM